These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37165953)

  • 21. Synchronized Ratiometric Codelivery of Metformin and Topotecan through Engineered Nanocarrier Facilitates In Vivo Synergistic Precision Levels at Tumor Site.
    Banala VT; Sharma S; Barnwal P; Urandur S; Shukla RP; Ahmad N; Mittapelly N; Pandey G; Dwivedi M; Kalleti N; Mitra K; Rath SK; Trivedi R; Mishra PR
    Adv Healthc Mater; 2018 Oct; 7(19):e1800300. PubMed ID: 30102470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solid lipid nanocarriers in drug delivery: characterization and design.
    Mu H; Holm R
    Expert Opin Drug Deliv; 2018 Aug; 15(8):771-785. PubMed ID: 30064267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dermal Delivery of Lipid Nanoparticles: Effects on Skin and Assessment of Absorption and Safety.
    Pinto F; Fonseca LP; de Barros DPC
    Adv Exp Med Biol; 2022; 1357():83-114. PubMed ID: 35583641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paclitaxel-Loaded Self-Assembled Lipid Nanoparticles as Targeted Drug Delivery Systems for the Treatment of Aggressive Ovarian Cancer.
    Zhai J; Luwor RB; Ahmed N; Escalona R; Tan FH; Fong C; Ratcliffe J; Scoble JA; Drummond CJ; Tran N
    ACS Appl Mater Interfaces; 2018 Aug; 10(30):25174-25185. PubMed ID: 29963859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
    Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
    Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy.
    Layek B; Gidwani B; Tiwari S; Joshi V; Jain V; Vyas A
    Curr Pharm Des; 2020; 26(27):3218-3233. PubMed ID: 32568015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin.
    Han Y; Zhang Y; Li D; Chen Y; Sun J; Kong F
    Int J Nanomedicine; 2014; 9():4107-16. PubMed ID: 25187713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functionalized Lipid-Polymer Hybrid Nanoparticles Mediated Codelivery of Methotrexate and Aceclofenac: A Synergistic Effect in Breast Cancer with Improved Pharmacokinetics Attributes.
    Garg NK; Tyagi RK; Sharma G; Jain A; Singh B; Jain S; Katare OP
    Mol Pharm; 2017 Jun; 14(6):1883-1897. PubMed ID: 28402673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
    Koning GA; Krijger GC
    Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effect of Millisecond Pulsed Electric Fields (msPEF) on Intracellular Drug Transport with Negatively Charged Large Nanocarriers Made of Solid Lipid Nanoparticles (SLN): In Vitro Study.
    Kulbacka J; Pucek A; Wilk KA; Dubińska-Magiera M; Rossowska J; Kulbacki M; Kotulska M
    J Membr Biol; 2016 Oct; 249(5):645-661. PubMed ID: 27173678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual-drug codelivery nanosystems: An emerging approach for overcoming cancer multidrug resistance.
    Gong J; Shi T; Liu J; Pei Z; Liu J; Ren X; Li F; Qiu F
    Biomed Pharmacother; 2023 May; 161():114505. PubMed ID: 36921532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What does the future hold for chemotherapy with the use of lipid-based nanocarriers?
    Pucci C; Martinelli C; Ciofani G
    Future Oncol; 2020 Feb; 16(5):81-84. PubMed ID: 31872773
    [No Abstract]   [Full Text] [Related]  

  • 33. Targeted drug therapy in nonsmall cell lung cancer: clinical significance and possible solutions-part II (role of nanocarriers).
    Yadav KS; Upadhya A; Misra A
    Expert Opin Drug Deliv; 2021 Jan; 18(1):103-118. PubMed ID: 33017541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanocarriers surface engineered with cell membranes for cancer targeted chemotherapy.
    Lei W; Yang C; Wu Y; Ru G; He X; Tong X; Wang S
    J Nanobiotechnology; 2022 Jan; 20(1):45. PubMed ID: 35062958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights on Oral Drug Delivery of Lipid Nanocarriers: a Win-Win Solution for Augmenting Bioavailability of Antiretroviral Drugs.
    Nabi B; Rehman S; Baboota S; Ali J
    AAPS PharmSciTech; 2019 Jan; 20(2):60. PubMed ID: 30623263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid-based nanocarriers for drug delivery and targeting: a patent survey of methods of production and characterization.
    Carbone C; Cupri S; Leonardi A; Puglisi G; Pignatello R
    Pharm Pat Anal; 2013 Sep; 2(5):665-77. PubMed ID: 24237173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors.
    Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P
    Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual-Drug Backboned Polyprodrug with a Predefined Drug Combination for Synergistic Chemotherapy.
    Yu F; Tu Y; Luo S; Xiao X; Yao W; Jiang M; Jiang X; Yang R; Yuan Y
    Nano Lett; 2021 Mar; 21(5):2216-2223. PubMed ID: 33635657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-Assembly of pH-Labile Polymer Nanoparticles for Paclitaxel Prodrug Delivery: Formulation, Characterization, and Evaluation.
    Levit SL; Gade NR; Roper TD; Yang H; Tang C
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Super-Resolution Imaging of Intracellular Lipid Nanocarriers to Study Drug Delivery in Photodynamic Therapy.
    Scutigliani EM; Kochan JA; Desclos ECB; Jonker A; Heger M; Krawczyk PM
    Methods Mol Biol; 2022; 2451():703-709. PubMed ID: 35505042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.